NRX Pharmaceuticals, Inc.
•1719406
NRx is a biopharmaceutical company focused on developing medicines for unmet medical needs within mental health, specifically suicidal depression, suicidal bipolar depression, and post-traumatic stress disorder (PTSD). They have filed for approval of NRX-100 (ketamine) for suicidal depression and are working on innovative therapies to save lives.
89
Meget PåliteligOffisielt Register
AI Kvalitetsanalyse
Tillitsscore Detaljer
Register Verifisert35/35
Kvalitetsscore54/60
Nyhetsanalyse0/5
Snarveier
Nettside Høydepunkter
Our Company - NRx Pharmaceuticals
We are NRx Pharmaceuticals - United in the mission of bringing life-saving treatments to patients.
Shareholder Update
Management Answers to Shareholder Questions
Investor Relations | NRx Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc. Investor relations (IR) website contains information about our business for stockholders, potential investors, and financial analysts.
Bipolar Depression & Suicidality - NRx Pharmaceuticals
Our Therapeutic Focus Bipolar Depression & Suicidality Bipolar disorder is an illness that affects approximately 7 million individuals in the USA1. It can cause
NRx Pharmaceuticals - We Bring Hope to Life
NRx Pharmaceuticals, Inc. draws upon decades of collective, scientific, and drug-development experience to address very high unmet needs of patients.
Sist oppdatert: 12/31/2025
🌟 Lignende Pålitelige Bedrifter
GTP BIOWAYS CDMO
G
76/100 · Pålitelig
OLON France er en erfaren CDMO som betjener biofarmasøytisk industri. De tilbyr et bredt spekter av tjenester, inkludert prosessutvikling, GMP-produksjon og analytisk utvikling for biologiske legemidler. Deres ekspertise omfatter produksjon i pattedyrceller, mikrobielle systemer og biokonjugater, noe som posisjonerer dem som en allsidig partner for legemiddelutvikling.
ACTISUD 18 RUE JEAN PERRIN 31100 TOULOUSE, Frankrike